| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 428.20M | 422.90M | 437.00M | 448.90M | 379.20M | 302.80M |
| Gross Profit | 186.40M | 181.50M | 177.00M | 36.30M | 27.40M | 104.00M |
| EBITDA | 76.20M | 74.50M | 62.90M | 63.10M | 46.00M | 37.60M |
| Net Income | 25.90M | 24.60M | 15.50M | 21.30M | 19.00M | 12.00M |
Balance Sheet | ||||||
| Total Assets | 691.40M | 695.00M | 668.70M | 585.70M | 592.70M | 428.20M |
| Cash, Cash Equivalents and Short-Term Investments | 140.90M | 139.30M | 110.80M | 83.90M | 108.80M | 29.20M |
| Total Debt | 262.30M | 261.00M | 234.90M | 145.40M | 160.10M | 97.90M |
| Total Liabilities | 378.10M | 387.00M | 367.10M | 282.10M | 302.30M | 219.80M |
| Stockholders Equity | 313.30M | 308.00M | 301.60M | 303.60M | 290.40M | 208.40M |
Cash Flow | ||||||
| Free Cash Flow | 46.40M | 40.30M | 36.30M | 32.10M | 25.10M | 42.40M |
| Operating Cash Flow | 52.40M | 46.40M | 41.20M | 37.70M | 31.30M | 46.30M |
| Investing Cash Flow | -23.30M | -19.30M | -83.80M | -30.70M | -53.00M | -24.40M |
| Financing Cash Flow | -23.50M | -13.90M | 33.20M | 1.20M | 29.30M | -27.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £504.64M | 10.73 | 8.34% | 2.09% | 0.49% | 61.73% | |
69 Neutral | £274.41M | 31.22 | 12.26% | 1.89% | 5.46% | -26.44% | |
68 Neutral | £79.02M | 20.27 | 16.76% | ― | -3.41% | 58.10% | |
67 Neutral | £205.83M | 25.56 | 3.10% | 2.19% | 10.66% | 21.19% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | £195.87M | -1.27 | -37.50% | ― | -16.33% | -448.12% | |
49 Neutral | £89.72M | -24.70 | -18.52% | ― | -7.35% | -222.10% |